Drug intelligence / Profile preview

calcium acetate + magnesium carbonate

Development stage
Phase 3
Lead developer
Fresenius Medical Care
Modality
Small Molecules
Administration
Oral
01

Overview

Calcium acetate + magnesium carbonate is an oral fixed-dose phosphate-binding medicine marketed as **OsvaRen** for hyperphosphataemia in adults with chronic kidney disease receiving dialysis. Each film-coated tablet contains calcium acetate 435 mg, providing 110 mg elemental calcium, and heavy magnesium carbonate 235 mg, providing 60 mg elemental magnesium. Taken with meals, its calcium and magnesium ions bind dietary phosphate in the gastrointestinal tract, forming poorly absorbed phosphate salts that are eliminated in faeces and thereby lower serum phosphate. The magnesium-containing formulation reduces calcium exposure relative to calcium-only phosphate binders, although serum calcium and magnesium require monitoring because hypercalcaemia and hypermagnesaemia may occur.

Brand names
OsvaRenRenephoRephoren
Other names
CaMgcalcium acetate/magnesium carbonatecalcium acetate/magnesium carbonate, heavy

Beyond the preview

Go deeper on calcium acetate + magnesium carbonate.

Explore the evidence, development activity, and competitive landscape with Gosset’s full data platform.

Clinical trials

Full profile access

Follow clinical development from study design and recruitment through results.

  • Trial phase
  • Status
  • Readouts

Indications & development

Full profile access

Explore development by indication, patient population, and geography.

  • Indications
  • Development status
  • Countries

Licensing & deals

Full profile access

Trace asset ownership, licensing agreements, and commercial partnerships.

  • Partners
  • Deal terms
  • Milestones

Patents & exclusivity

Full profile access

Explore the patent landscape and regulatory exclusivity around an asset.

  • Patents
  • Expiration dates
  • Exclusivity

Competitive landscape

Full profile access

Compare development programs by target, modality, and indication.

  • Competing assets
  • Targets
  • Development stage

Research & analysis

Full profile access

Connect source evidence and development news to your research questions.

  • Publications
  • News
  • Analysis

Bring the full picture into focus.

See how Gosset can support your research on calcium acetate + magnesium carbonate.

Explore the full profile

Gosset Free

Get started with Gosset.

Enter your work email and we’ll be in touch with next steps.

Work email preferred.

Book a call